Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-137676

Atara Biotherapeutics, Inc. · ATRA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
John McGrath
Officer — Chief Financial Officer
Period of report
Aug 15, 2016
Accepted (ET)
Aug 17, 2016 · 7:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604464

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Aug 15, 2016M2,804$0.00A91,626D
Common StockF1Aug 15, 2016M7,697$0.00A99,323D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF5,F2,F3,F4—Aug 15, 2016M2,804D——Common Stock2,8046,544I
Restricted Stock UnitsF5,F2,F6,F7—Aug 15, 2016M7,697D——Common Stock7,69743,619I

Explanation of responses